TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 75 filers reported holding TARSUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $27,575,522 | +23.5% | 1,551,802 | +25.6% | 0.00% | 0.0% |
| Q2 2023 | $22,328,629 | +44.9% | 1,235,674 | +0.8% | 0.00% | – |
| Q1 2023 | $15,405,050 | -13.3% | 1,225,541 | +1.1% | 0.00% | – |
| Q4 2022 | $17,774,811 | +11.0% | 1,212,470 | +29.6% | 0.00% | – |
| Q3 2022 | $16,018,000 | +67.3% | 935,649 | +42.7% | 0.00% | – |
| Q2 2022 | $9,575,000 | +24.1% | 655,823 | +42.9% | 0.00% | – |
| Q1 2022 | $7,717,000 | -25.3% | 458,816 | -0.1% | 0.00% | – |
| Q4 2021 | $10,332,000 | +11.8% | 459,190 | +7.0% | 0.00% | – |
| Q3 2021 | $9,245,000 | -25.1% | 428,990 | +0.7% | 0.00% | – |
| Q2 2021 | $12,347,000 | +40.3% | 426,045 | +56.1% | 0.00% | – |
| Q1 2021 | $8,799,000 | -21.4% | 272,990 | +0.8% | 0.00% | – |
| Q4 2020 | $11,197,000 | – | 270,891 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,084,370 | $30,432,000 | 4.62% |
| Vivo Capital, LLC | 2,312,368 | $33,761,000 | 3.39% |
| Frazier Life Sciences Management, L.P. | 1,787,527 | $26,098,000 | 2.46% |
| Cormorant Asset Management, LP | 1,875,000 | $27,375,000 | 2.07% |
| Sands Capital Ventures, LLC | 260,000 | $3,796,000 | 1.04% |
| Ghost Tree Capital, LLC | 120,000 | $1,752,000 | 0.91% |
| RTW INVESTMENTS, LP | 2,013,601 | $29,399,000 | 0.76% |
| COWEN AND COMPANY, LLC | 534,524 | $7,804,000 | 0.75% |
| Perceptive Advisors | 1,296,416 | $18,927,000 | 0.59% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,324,214 | $19,334,000 | 0.40% |